Almirall
Almirall is a leading global biopharmaceutical company headquartered in Barcelona, specializing in medical dermatology. Founded in 1943, the company focuses on providing innovative solutions for skin health, covering a wide range of conditions from psoriasis to actinic keratosis. With a presence in over 21 countries and a workforce of approximately 1,900 employees, Almirall is a key player in the European pharmaceutical sector and is listed on the Spanish Stock Exchange. As a Spanish-founded company with its global headquarters in Barcelona, Almirall offers a unique blend of local heritage and international reach. The company maintains significant R&D and manufacturing facilities in the Barcelona area, making it a hub for scientific and technical talent. For international professionals, Almirall provides a diverse and collaborative environment where English is frequently used in global functions, along with structured trainee programs and opportunities for career progression in specialized fields like biotechnology and clinical development.
Company History
Founded in 1943 in Barcelona, Almirall began as a local pharmaceutical firm before expanding internationally through strategic acquisitions and a focus on R&D. It went public on the Spanish Stock Exchange in 2007 and has since pivoted its core strategy to become a global leader in medical dermatology.